102 results
8-K
EX-4.3
SBFM
Sunshine Biopharma Inc
15 Feb 24
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
11:39am
of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3.7 regardless of (i) whether the Company has sufficient
8-K
EX-4.2
SBFM
Sunshine Biopharma Inc
15 Feb 24
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
11:39am
, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section
8-K
EX-1.1
SBFM
Sunshine Biopharma Inc
15 Feb 24
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
11:39am
provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing … benefits accrued under such Plan (determined based on those assumptions used to fund such Plan) and (D) neither the Company or any member of its
424B4
7cv3ys
14 Feb 24
Prospectus supplement with pricing info
11:18am
S-8
EX-4.1
3zego vo8
8 Jan 24
Registration of securities for employees
8:10am
CORRESP
8uo zqvohoh2vlq
8 Aug 23
Correspondence with SEC
12:00am
8-K
EX-10.2
3z3ggb26
16 May 23
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
4:05pm
8-K
EX-10.1
no7rm5
16 May 23
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
4:05pm
8-K
EX-99.1
35owm6h5
16 May 23
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
4:05pm
PRE 14A
k11z5d
2 May 23
Preliminary proxy
1:57pm